ALPMY
Price
$9.66
Change
-$0.21 (-2.13%)
Updated
Jun 5 closing price
Capitalization
26.55B
54 days until earnings call
CHGCY
Price
$25.57
Change
-$0.35 (-1.35%)
Updated
Jun 5 closing price
Capitalization
49.42B
Interact to see
Advertisement

ALPMY vs CHGCY

Header iconALPMY vs CHGCY Comparison
Open Charts ALPMY vs CHGCYBanner chart's image
Astellas Pharma
Price$9.66
Change-$0.21 (-2.13%)
Volume$181.29K
Capitalization26.55B
Chugai Pharmaceutical
Price$25.57
Change-$0.35 (-1.35%)
Volume$454.95K
Capitalization49.42B
ALPMY vs CHGCY Comparison Chart
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. CHGCY commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Buy and CHGCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ALPMY: $9.66 vs. CHGCY: $25.57)
Brand notoriety: ALPMY and CHGCY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 95% vs. CHGCY: 234%
Market capitalization -- ALPMY: $26.55B vs. CHGCY: $49.42B
ALPMY [@Pharmaceuticals: Major] is valued at $26.55B. CHGCY’s [@Pharmaceuticals: Major] market capitalization is $49.42B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileCHGCY’s FA Score has 1 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • CHGCY’s FA Score: 1 green, 4 red.
According to our system of comparison, CHGCY is a better buy in the long-term than ALPMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 8 TA indicator(s) are bullish while CHGCY’s TA Score has 4 bullish TA indicator(s).

  • ALPMY’s TA Score: 8 bullish, 2 bearish.
  • CHGCY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than CHGCY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а -0.41% price change this week, while CHGCY (@Pharmaceuticals: Major) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.15%. For the same industry, the average monthly price growth was +3.71%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

ALPMY is expected to report earnings on Jul 30, 2025.

CHGCY is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.15% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCY($49.4B) has a higher market cap than ALPMY($26.6B). ALPMY has higher P/E ratio than CHGCY: ALPMY (37.59) vs CHGCY (21.46). CHGCY YTD gains are higher at: 16.386 vs. ALPMY (0.000). CHGCY has higher annual earnings (EBITDA): 458B vs. ALPMY (247B). CHGCY has more cash in the bank: 665B vs. ALPMY (397B). CHGCY has less debt than ALPMY: CHGCY (215M) vs ALPMY (30B). ALPMY has higher revenues than CHGCY: ALPMY (1.52T) vs CHGCY (1.24T).
ALPMYCHGCYALPMY / CHGCY
Capitalization26.6B49.4B54%
EBITDA247B458B54%
Gain YTD0.00016.386-
P/E Ratio37.5921.46175%
Revenue1.52T1.24T122%
Total Cash397B665B60%
Total Debt30B215M13,953%
FUNDAMENTALS RATINGS
ALPMY vs CHGCY: Fundamental Ratings
ALPMY
CHGCY
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
10041
PRICE GROWTH RATING
1..100
7348
P/E GROWTH RATING
1..100
9826
SEASONALITY SCORE
1..100
n/a48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (4) in the null industry is significantly better than the same rating for CHGCY (81). This means that ALPMY’s stock grew significantly faster than CHGCY’s over the last 12 months.

CHGCY's Profit vs Risk Rating (64) in the null industry is somewhat better than the same rating for ALPMY (100). This means that CHGCY’s stock grew somewhat faster than ALPMY’s over the last 12 months.

CHGCY's SMR Rating (41) in the null industry is somewhat better than the same rating for ALPMY (100). This means that CHGCY’s stock grew somewhat faster than ALPMY’s over the last 12 months.

CHGCY's Price Growth Rating (48) in the null industry is in the same range as ALPMY (73). This means that CHGCY’s stock grew similarly to ALPMY’s over the last 12 months.

CHGCY's P/E Growth Rating (26) in the null industry is significantly better than the same rating for ALPMY (98). This means that CHGCY’s stock grew significantly faster than ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYCHGCY
RSI
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 11 days ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGPIX103.45N/A
N/A
ProFunds Mid Cap Growth Inv
DRTCX19.24N/A
N/A
BNY Mellon Sust US Equity I
OLVAX20.10N/A
N/A
JPMorgan Large Cap Value A
GGGPX40.49N/A
N/A
Goldman Sachs Large Cap Equity P
BUIMX16.90N/A
N/A
Buffalo Mid Cap Growth Inst

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-2.13%
ALPMF - ALPMY
38%
Loosely correlated
N/A
OPHLY - ALPMY
33%
Loosely correlated
-1.13%
CHGCY - ALPMY
22%
Poorly correlated
-1.35%
DSNKY - ALPMY
21%
Poorly correlated
-5.07%
OTSKY - ALPMY
20%
Poorly correlated
-0.99%
More

CHGCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHGCY has been loosely correlated with DSNKY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHGCY jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
-1.35%
DSNKY - CHGCY
38%
Loosely correlated
-5.07%
OTSKY - CHGCY
32%
Poorly correlated
-0.99%
OPHLY - CHGCY
32%
Poorly correlated
-1.13%
CHGCF - CHGCY
28%
Poorly correlated
N/A
DSKYF - CHGCY
23%
Poorly correlated
-7.91%
More